Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahim Abbasi

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Metabolism: Clinical and Experimental|June 3, 2011
Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterolFahim Abbasi, Gerald M Reaven
Endocrinology and Metabolism (Seoul, Korea)|March 27, 2019
Myths about Insulin Resistance: Tribute to Gerald ReavenSun H Kim, Fahim Abbasi
Recent Progress in Hormone Research|January 30, 2004
Obesity, insulin resistance, and cardiovascular diseaseGerald Reaven, Fahim Abbasi, Tracey McLaughlin
The American Journal of Clinical Nutrition|December 25, 2009
Fasting urine pH is independent of insulin sensitivityBiruh Workeneh, Fahim Abbasi, Gerald Reaven
The American Journal of Clinical Nutrition|July 26, 2013
Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity?Fahim Abbasi, Christine Blasey, Gerald M Reaven
Acta Diabetologica|February 20, 2013
Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)Fahim Abbasi, QueenDenise Okeke, Gerald M Reaven
Metabolism: Clinical and Experimental|April 2, 2010
What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure itFahim Abbasi, Cindy Lamendola, Gerald M Reaven
Diabetes Care|July 28, 2004
Impact of degree of obesity on surrogate estimates of insulin resistanceSun H Kim, Fahim Abbasi, Gerald M Reaven
Archives of Internal Medicine|April 11, 2007
Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivityTracey McLaughlin, Fahim Abbasi, Cindy Lamendola, et al.
Clinical Chemistry|February 8, 2011
Estimates of insulin secretory function in apparently healthy volunteers vary as a function of how the relevant variables are quantifiedBarry R Johns, Fahim Abbasi, Gerald M Reaven
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Metabolism: Clinical and Experimental|June 3, 2011
Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterolFahim Abbasi, Gerald M Reaven
Endocrinology and Metabolism (Seoul, Korea)|March 27, 2019
Myths about Insulin Resistance: Tribute to Gerald ReavenSun H Kim, Fahim Abbasi
Recent Progress in Hormone Research|January 30, 2004
Obesity, insulin resistance, and cardiovascular diseaseGerald Reaven, Fahim Abbasi, Tracey McLaughlin
The American Journal of Clinical Nutrition|December 25, 2009
Fasting urine pH is independent of insulin sensitivityBiruh Workeneh, Fahim Abbasi, Gerald Reaven
The American Journal of Clinical Nutrition|July 26, 2013
Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity?Fahim Abbasi, Christine Blasey, Gerald M Reaven
Acta Diabetologica|February 20, 2013
Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)Fahim Abbasi, QueenDenise Okeke, Gerald M Reaven
Metabolism: Clinical and Experimental|April 2, 2010
What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure itFahim Abbasi, Cindy Lamendola, Gerald M Reaven
Diabetes Care|July 28, 2004
Impact of degree of obesity on surrogate estimates of insulin resistanceSun H Kim, Fahim Abbasi, Gerald M Reaven
Archives of Internal Medicine|April 11, 2007
Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivityTracey McLaughlin, Fahim Abbasi, Cindy Lamendola, et al.
Clinical Chemistry|February 8, 2011
Estimates of insulin secretory function in apparently healthy volunteers vary as a function of how the relevant variables are quantifiedBarry R Johns, Fahim Abbasi, Gerald M Reaven
Pageof 12